The University of Southampton
University of Southampton Institutional Repository

Placebo effects are small on average in the 7.5% CO2 inhalational model of generalised anxiety

Placebo effects are small on average in the 7.5% CO2 inhalational model of generalised anxiety
Placebo effects are small on average in the 7.5% CO2 inhalational model of generalised anxiety

Background: anxiety disorders are highly prevalent and socio-economically costly. Novel pharmacological treatments for these disorders are needed as many patients do not respond to current agents or experience unwanted side-effects. However, a barrier to treatment development is the variable and large placebo response rate seen in trials of novel anxiolytics. Despite this, the mechanisms that drive placebo responses in anxiety disorders have been little investigated, possibly due to low availability of convenient experimental paradigms. We aimed to develop and test a novel protocol for inducing placebo anxiolysis in the 7.5% CO2 inhalational model of generalised anxiety in healthy volunteers.

Methods: following a baseline 20-minute CO2 challenge, 32 healthy volunteers were administered a placebo intranasal spray labelled as either the anxiolytic 'lorazepam' or 'saline'. Following this, participants surreptitiously underwent a 20-minute inhalation of normal air. Post-conditioning, a second dose of the placebo was administered, after which participants completed another CO2 challenge.

Results: participants administered sham 'lorazepam' reported significant positive expectations of reduced anxiety (p = 0.001) but there was no group-level placebo effect on anxiety following CO2 challenge post-conditioning (p's > 0.350). Surprisingly, we found many participants exhibited unexpected worsening of anxiety, despite positive expectations.

Conclusions: contrary to our hypothesis, our novel paradigm did not induce a placebo response, on average. It is possible that effects of 7.5% CO2 inhalation on prefrontal cortex function, or behaviour in line with a Bayesian predictive coding framework, attenuated the effect of expectations on subsequent placebo response. Future studies are needed to explore these possibilities.

1461-1457
Huneke, Nathan T.M.
d1be843a-7aab-4978-9b4d-5bcc69b178a7
Cross, Cosmina
883fdd80-0f6a-438b-8352-28d7605afd24
Fagan, Harry A.
e288acbf-f233-4d8e-b304-23cde72dd29e
Molteni, Laura
1b55e314-9610-44cc-95bb-9613be57f375
Phillips, Naomi
eba189b9-55d6-4301-b6d1-9a1c8cf4528b
Garner, Matthew
3221c5b3-b951-4fec-b456-ec449e4ce072
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Huneke, Nathan T.M.
d1be843a-7aab-4978-9b4d-5bcc69b178a7
Cross, Cosmina
883fdd80-0f6a-438b-8352-28d7605afd24
Fagan, Harry A.
e288acbf-f233-4d8e-b304-23cde72dd29e
Molteni, Laura
1b55e314-9610-44cc-95bb-9613be57f375
Phillips, Naomi
eba189b9-55d6-4301-b6d1-9a1c8cf4528b
Garner, Matthew
3221c5b3-b951-4fec-b456-ec449e4ce072
Baldwin, David S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e

Huneke, Nathan T.M., Cross, Cosmina, Fagan, Harry A., Molteni, Laura, Phillips, Naomi, Garner, Matthew and Baldwin, David S. (2024) Placebo effects are small on average in the 7.5% CO2 inhalational model of generalised anxiety. International Journal of Neuropsychopharmacology, [pyae019]. (doi:10.1093/ijnp/pyae019).

Record type: Article

Abstract

Background: anxiety disorders are highly prevalent and socio-economically costly. Novel pharmacological treatments for these disorders are needed as many patients do not respond to current agents or experience unwanted side-effects. However, a barrier to treatment development is the variable and large placebo response rate seen in trials of novel anxiolytics. Despite this, the mechanisms that drive placebo responses in anxiety disorders have been little investigated, possibly due to low availability of convenient experimental paradigms. We aimed to develop and test a novel protocol for inducing placebo anxiolysis in the 7.5% CO2 inhalational model of generalised anxiety in healthy volunteers.

Methods: following a baseline 20-minute CO2 challenge, 32 healthy volunteers were administered a placebo intranasal spray labelled as either the anxiolytic 'lorazepam' or 'saline'. Following this, participants surreptitiously underwent a 20-minute inhalation of normal air. Post-conditioning, a second dose of the placebo was administered, after which participants completed another CO2 challenge.

Results: participants administered sham 'lorazepam' reported significant positive expectations of reduced anxiety (p = 0.001) but there was no group-level placebo effect on anxiety following CO2 challenge post-conditioning (p's > 0.350). Surprisingly, we found many participants exhibited unexpected worsening of anxiety, despite positive expectations.

Conclusions: contrary to our hypothesis, our novel paradigm did not induce a placebo response, on average. It is possible that effects of 7.5% CO2 inhalation on prefrontal cortex function, or behaviour in line with a Bayesian predictive coding framework, attenuated the effect of expectations on subsequent placebo response. Future studies are needed to explore these possibilities.

Text
pyae019 - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (1MB)

More information

e-pub ahead of print date: 5 April 2024

Identifiers

Local EPrints ID: 488969
URI: http://eprints.soton.ac.uk/id/eprint/488969
ISSN: 1461-1457
PURE UUID: 186bab7e-8754-4ac6-8b3d-313e938a585f
ORCID for Matthew Garner: ORCID iD orcid.org/0000-0001-9481-2226
ORCID for David S. Baldwin: ORCID iD orcid.org/0000-0003-3343-0907

Catalogue record

Date deposited: 10 Apr 2024 16:33
Last modified: 11 Apr 2024 01:37

Export record

Altmetrics

Contributors

Author: Nathan T.M. Huneke
Author: Cosmina Cross
Author: Harry A. Fagan
Author: Laura Molteni
Author: Naomi Phillips
Author: Matthew Garner ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×